BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar C, Shetake N, Desai S, Kumar A, Samuel G, Pandey BN. Relevance of radiobiological concepts in radionuclide therapy of cancer. Int J Radiat Biol 2016;92:173-86. [PMID: 26917443 DOI: 10.3109/09553002.2016.1144944] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Kumar C, Sharma R, Das T, Korde A, Sarma H, Banerjee S, Dash A. 177 Lu-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell line. J Label Compd Radiopharm 2018;61:837-46. [DOI: 10.1002/jlcr.3651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Desai S, Srambikkal N, Yadav HD, Shetake N, Balla MM, Kumar A, Ray P, Ghosh A, Pandey BN. Molecular Understanding of Growth Inhibitory Effect from Irradiated to Bystander Tumor Cells in Mouse Fibrosarcoma Tumor Model. PLoS One 2016;11:e0161662. [PMID: 27561007 DOI: 10.1371/journal.pone.0161662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Montel AM, Dos Santos RG, da Costa PR, Silveira-Lacerda EP, Batista AA, Dos Santos WG. Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene. Biometals 2017;30:295-305. [PMID: 28258507 DOI: 10.1007/s10534-017-0006-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Zhao X, Cui J, Hu J, Gao S, Liu X. Effects of low-dose radiation on adaptive response in colon cancer stem cells. Clin Transl Oncol 2017;19:907-14. [DOI: 10.1007/s12094-017-1624-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
5 Goulet DR, Atkins WM. Considerations for the Design of Antibody-Based Therapeutics. J Pharm Sci 2020;109:74-103. [PMID: 31173761 DOI: 10.1016/j.xphs.2019.05.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
6 Bao G, Tang M, Zhao J, Zhu X. Nanobody: a promising toolkit for molecular imaging and disease therapy. EJNMMI Res 2021;11:6. [PMID: 33464410 DOI: 10.1186/s13550-021-00750-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Sapienza MT, Willegaignon J. Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning. Clinics (Sao Paulo) 2019;74:e835. [PMID: 31365617 DOI: 10.6061/clinics/2019/e835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
8 Hrubý M, Kučka J, Pánek J, Štěpánek P. Seven years of radionuclide laboratory at IMC - important achievements. Physiol Res 2016;65:S191-201. [PMID: 27762585 DOI: 10.33549/physiolres.933421] [Reference Citation Analysis]
9 Nunes RF, Zuppani RMF, Coutinho AM, Barbosa FG, Sapienza MT, Marin JFG, Buchpiguel CA. General Concepts in Theranostics. PET Clin 2021;16:313-26. [PMID: 34053576 DOI: 10.1016/j.cpet.2021.03.010] [Reference Citation Analysis]
10 Gholami YH, Willowson KP, Forwood NJ, Harvie R, Hardcastle N, Bromley R, Ryu H, Yuen S, Howell VM, Kuncic Z, Bailey DL. Comparison of radiobiological parameters for 90Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro. EJNMMI Phys 2018;5:18. [PMID: 30175390 DOI: 10.1186/s40658-018-0217-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
11 Rathke H, Giesel FL, Flechsig P, Kopka K, Mier W, Hohenfellner M, Haberkorn U, Kratochwil C. Repeated 177Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq. J Nucl Med 2018;59:459-65. [PMID: 28798031 DOI: 10.2967/jnumed.117.194209] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
12 Morris ZS, Wang AZ, Knox SJ. The Radiobiology of Radiopharmaceuticals. Semin Radiat Oncol 2021;31:20-7. [PMID: 33246632 DOI: 10.1016/j.semradonc.2020.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yadav R, Agrawal AK, Ali M, Kumar A, Singh B, Kashyap Y, Sinha A, Gadkari SC, Pandey BN. Thorium-induced Anatomical and Histopathological Changes in Liver of Swiss Mice. Toxicol Environ Health Sci 2018;10:97-106. [DOI: 10.1007/s13530-018-0352-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Spetz J, Rudqvist N, Langen B, Parris TZ, Dalmo J, Schüler E, Wängberg B, Nilsson O, Helou K, Forssell-Aronsson E. Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy. Nucl Med Biol 2018;60:11-8. [PMID: 29502008 DOI: 10.1016/j.nucmedbio.2018.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Asadian S, Mirzaei H, Kalantari BA, Davarpanah MR, Mohamadi M, Shpichka A, Nasehi L, Es HA, Timashev P, Najimi M, Gheibi N, Hassan M, Vosough M. β-radiating radionuclides in cancer treatment, novel insight into promising approach. Pharmacol Res 2020;160:105070. [PMID: 32659429 DOI: 10.1016/j.phrs.2020.105070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Cirrone GAP, Manti L, Margarone D, Petringa G, Giuffrida L, Minopoli A, Picciotto A, Russo G, Cammarata F, Pisciotta P, Perozziello FM, Romano F, Marchese V, Milluzzo G, Scuderi V, Cuttone G, Korn G. First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness. Sci Rep 2018;8:1141. [PMID: 29348437 DOI: 10.1038/s41598-018-19258-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
17 Swati, Chadha VD. Role of epigenetic mechanisms in propagating off-targeted effects following radiation based therapies - A review. Mutat Res Rev Mutat Res 2021;787:108370. [PMID: 34083045 DOI: 10.1016/j.mrrev.2021.108370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Dale RG. Radiation repair models for clinical application. Br J Radiol 2019;92:20180070. [PMID: 29470100 DOI: 10.1259/bjr.20180070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Rajan V, Pandey BN. Cytoproliferative effect of low dose alpha radiation in human lung cancer cells is associated with connexin 43, caveolin-1, and survivin pathway. Int J Radiat Biol 2021;97:356-66. [PMID: 33416428 DOI: 10.1080/09553002.2021.1864044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]